These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 36795134)
1. Biventricular impella (BiPella) utilization in fulminant COVID-19 myopericarditis-mediated cardiogenic shock during pregnancy. Srichawla BS; Sekhon M Clin Res Cardiol; 2023 Oct; 112(10):1475-1478. PubMed ID: 36795134 [No Abstract] [Full Text] [Related]
2. Acute mechanical circulatory support for fulminant myocarditis complicated by cardiogenic shock. Mody KP; Takayama H; Landes E; Yuzefpolskaya M; Colombo PC; Naka Y; Jorde UP; Uriel N J Cardiovasc Transl Res; 2014 Mar; 7(2):156-64. PubMed ID: 24420915 [TBL] [Abstract][Full Text] [Related]
3. Short-term use of "ECMELLA" in the context of fulminant eosinophilic myocarditis with cardiogenic shock. Bohné M; Chung DU; Tigges E; van der Schalk H; Waddell D; Schenker N; Willems S; Klingel K; Kivelitz D; Bahlmann E BMC Cardiovasc Disord; 2020 Dec; 20(1):519. PubMed ID: 33302874 [TBL] [Abstract][Full Text] [Related]
4. Severe COVID-19-associated myocarditis with cardiogenic shock - management with assist devices - a case report & review. Noone S; Flinspach AN; Fichtlscherer S; Zacharowski K; Sonntagbauer M; Raimann FJ BMC Anesthesiol; 2022 Dec; 22(1):385. PubMed ID: 36503438 [TBL] [Abstract][Full Text] [Related]
5. Total percutaneous biventricular assist device implantation for fulminant myocarditis. Tominaga Y; Toda K; Miyagawa S; Yoshioka D; Kainuma S; Kawamura T; Kawamura A; Nakamoto K; Sakata Y; Sawa Y J Artif Organs; 2021 Jun; 24(2):254-257. PubMed ID: 32748246 [TBL] [Abstract][Full Text] [Related]
6. The Impella Microaxial Flow Catheter Is Safe and Effective for Treatment of Myocarditis Complicated by Cardiogenic Shock: An Analysis From the Global cVAD Registry. Annamalai SK; Esposito ML; Jorde L; Schreiber T; A Hall S; O'Neill WW; Kapur NK J Card Fail; 2018 Oct; 24(10):706-710. PubMed ID: 30244180 [TBL] [Abstract][Full Text] [Related]
7. Simple method of left ventricular assist system exchange from a BVS-5000 to a Toyobo: case report of a patient with fulminant myocarditis. Ohata T; Mitsuno M; Yamamura M; Tanaka H; Kobayashi Y; Ryomoto M; Yoshioka Y; Tsujiya N; Miyamoto Y J Artif Organs; 2007; 10(4):228-30. PubMed ID: 18071853 [TBL] [Abstract][Full Text] [Related]
8. Mechanical Unloading by Fulminant Myocarditis: LV-IMPELLA, ECMELLA, BI-PELLA, and PROPELLA Concepts. Tschöpe C; Van Linthout S; Klein O; Mairinger T; Krackhardt F; Potapov EV; Schmidt G; Burkhoff D; Pieske B; Spillmann F J Cardiovasc Transl Res; 2019 Apr; 12(2):116-123. PubMed ID: 30084076 [TBL] [Abstract][Full Text] [Related]
9. Why can flu be so deadly? An unusual case of cardiogenic shock. Ciabatti M; Vignini E; Mattesini A; Di Mario C; Valente S Intern Emerg Med; 2020 Jun; 15(4):679-684. PubMed ID: 31104304 [No Abstract] [Full Text] [Related]
10. Pediatric Biventricular Assist Device for Myocarditis and Complicated Left Ventricular Thrombus. Tatewaki H; Hirata Y; Tanoue Y; Shiose A Ann Thorac Surg; 2019 May; 107(5):e307-e308. PubMed ID: 30403982 [TBL] [Abstract][Full Text] [Related]
11. Rescue Venoarterial Extracorporeal Membrane Oxygenation After Cardiac Arrest in COVID-19 Myopericarditis: A Case Report. Sampaio PPN; Ferreira RM; de Albuquerque FN; Colafranceschi AS; Almeida ACP; Nunes MAV; Mansur Filho J; Lima RAC Cardiovasc Revasc Med; 2021 Jul; 28S():57-60. PubMed ID: 33036920 [TBL] [Abstract][Full Text] [Related]
12. Safety and usefulness of left ventricular endomyocardial biopsy in new- onset acute heart failure requiring mechanical support by an Impella® device. Tschöpe C; Nelki V; Trippel TD; Klingel K; Abawi D; Alogna A Int J Cardiol; 2022 Dec; 368():49-52. PubMed ID: 35944774 [TBL] [Abstract][Full Text] [Related]
13. Use of percutaneous cardiopulmonary support of patients with fulminant myocarditis and cardiogenic shock for improving prognosis. Kato S; Morimoto S; Hiramitsu S; Nomura M; Ito T; Hishida H Am J Cardiol; 1999 Feb; 83(4):623-5, A10. PubMed ID: 10073879 [TBL] [Abstract][Full Text] [Related]
14. The Clinical Potential of Impella 5.0 Support in the Treatment of Recurrent Fulminant Viral Myocarditis with Profound Cardiogenic Shock. Ogawa S; Suzuki M; Ochi H; Saji M; Mahara K; Takamisawa I; Nishigawa K; Furuichi Y; Takanashi S; Isobe M Intern Med; 2019 May; 58(10):1459-1462. PubMed ID: 30626823 [TBL] [Abstract][Full Text] [Related]
16. Peripheral extracorporeal membrane oxygenation: a useful option to allow recovery in acute cardiogenic shock. Di Bella I; Da Col U; Ramoni E; Bardelli G; Vidili A; Ragni T J Cardiovasc Med (Hagerstown); 2011 Sep; 12(9):681-5. PubMed ID: 21796060 [No Abstract] [Full Text] [Related]
17. Facilitated cardiac recovery in fulminant myocarditis: pediatric use of the Impella LP 5.0 pump. Andrade JG; Al-Saloos H; Jeewa A; Sandor GG; Cheung A J Heart Lung Transplant; 2010 Jan; 29(1):96-7. PubMed ID: 19782584 [TBL] [Abstract][Full Text] [Related]
18. Seronegative immune-mediated necrotising myopathy complicated by fulminant myocarditis resulting in cardiogenic shock and cardiac arrest. Tsang D; Malladi CL; Patel K; Bajaj P BMJ Case Rep; 2022 Apr; 15(4):. PubMed ID: 35379682 [TBL] [Abstract][Full Text] [Related]
19. The role of Impella percutaneous left ventricular assist device in the management of cardiogenic shock: A matter of where and when. Tarantini G; Rodinò G Catheter Cardiovasc Interv; 2022 Jan; 99(1):48-49. PubMed ID: 34994514 [No Abstract] [Full Text] [Related]
20. Trans-subclavian approach for Impella CP implantation using the chimney graft in a pediatric patient with fulminant myocarditis during extracorporeal support. Hirose M; Ishida H; Kawamura T; Narita J; Ishii R; Watanabe T; Taira M; Ueno T; Ozono K; Miyagawa S J Artif Organs; 2023 Sep; 26(3):242-245. PubMed ID: 36224293 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]